For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT02339571
Contact name
Steven Schmitt
Clinical trials study type
Clinical trials trial status
IRB number
810609
Principal investigator
Mei Tang, MD
Clinical trials study number
EA6141
Phone
443-849-3285
Clinical trials title (full)
EA6141: Randomized Phase II/III Study of Nivolumab plus Ipilimumab plus Sargramostim vervus Nivolumab plus Ipilimuman in Patients with Unresectable Stage III or Stage IV Melanoma